Axicabtagene ciloleucel
daiichi sankyo,gilead
['bet', 'zuma1,(-zuma12),(-zuma14)']
 @ astct longitudinal samples from 32 patients treated on zuma1 shows higher cd8 ratio, lower t r g correlates with durable response. pr senter : giulia ch loniens 